Provided is an individually-wrapped sanitary napkin N, in which a sanitary napkin 1 is folded lengthwise with a wrapping sheet 10 and wrapped individually, the sanitary napkin 1 including an inner surface sheet 3 that constitutes a skin-contacting surface layer and a pair of wing-like flaps W that have wing adhesive layers 9 for fixing the wing-like flaps W to the underwear. The wing-like flaps W are both folded to the skin-contacting surface side, and the wing adhesive layers 9, provided in the folded portions of the wing-like flaps W, are collectively covered by a wing separating sheet 12, and a functional chemical 20 having a specific function is contained in the inner surface sheet 3 in the area where the wing separating sheet 12 is layered.

An absorbent article having a liquid pervious topsheet wherein at least a portion of the topsheet has been treated to become hydrophobic; a backsheet joined to said topsheet; an absorbent core disposed between said topsheet and said backsheet, said absorbent core having an inner surface oriented toward the skin of the wearer when said absorbent article is being worn and an outer surface oriented toward the garment of the wearer when said absorbent article is being worn; and a surfactant applied to at least a portion of said outer surface of said topsheet wherein the topsheet has been treated hydrophobic and wherein the hydrophilic surfactant is added to the areas treated hydrophobic.

The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyimide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyimide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

An application member includes a stimuli-responsive polymer that reversibly changes to being hydrophilic and to being hydrophobic in response to an external stimulus to allow impregnation and release of an active ingredient to be applied to the skin.

Described are systems and methods for monitoring administration of nitric oxide (NO) to ex vivo fluids. Examples of such fluids include blood in extracorporeal membrane oxygenation (ECMO) circuits or perfusion fluids used for preserving ex vivo organs prior to transplanting in a recipient. The systems and methods described herein provide for administering nitric oxide to the fluid, monitoring nitric oxide or a nitric oxide marker in the fluid, and adjusting the nitric oxide administration.

A diaper for collecting biological samples relates to light industry, and more particularly to a diaper for use in medical examinations and in diagnosing a person's state of health on the basis of an analysis of secretions and/or excreta of the individual. The technical aim of the invention is to create a diaper for the quick and efficient collection of biological samples, the use of which is not restricted by a particular type of indicator substance, and the structural characteristics of which provide for simple, convenient and efficient use. The present diaper (1) for collecting biological samples consists of at least a secretion and/or excreta absorbing base and a detachable absorbing layer (3). The secretion and/or excreta absorbing base of the diaper is provided with at least one through-hole (2). The hole is hermetically sealed on the outside by a sampling element consisting of the detachable absorbing layer and also of a water-impermeable layer (4) and a retaining layer (5).

A diaper for collecting biological samples relates to light industry, and more particularly to a diaper for use in medical examinations and in diagnosing a person's state of health on the basis of an analysis of secretions and/or excreta of the individual. The technical aim of the invention is to create a diaper for the quick and efficient collection of biological samples, the use of which is not restricted by a particular type of indicator substance, and the structural characteristics of which provide for simple, convenient and efficient use. The present diaper (1) for collecting biological samples consists of at least a secretion and/or excreta absorbing base and a detachable absorbing layer (3). The secretion and/or excreta absorbing base of the diaper is provided with at least one through-hole (2). The hole is hermetically sealed on the outside by a sampling element consisting of the detachable absorbing layer and also of a water-impermeable layer (4) and a retaining layer (5).

A respiratory expellant containment pad including a base layer and a containment layer on a first side of the base layer. The containment layer is configured to contain respiratory expellant from a wearer of the containment pad. An adhesive layer on a second side of the base layer is opposite to the containment layer.

A novel fibrinogen-based tissue adhesive patch is disclosed. The patch comprises a backing made from a non-permeable biocompatible polymer film into which a fibrinogen-based sealant is incorporated. In preferred embodiments of the invention, the biocompatible polymer film comprises units of a biocompatible block copolymer such as a polyethylene glycol-polycaprolactone-DL-lactide copolymer connected by urethane linkages, and the fibrinogen-based sealant comprises fibrinogen, thrombin, and CaCl.sub.2. In contrast to similar patches known in the art, the polymer backing serves to seal the tissue to which the patch is applied, and the sealant acts only to bind the patch to the affected tissue. The patch does not include any mesh, woven, or non-woven component. Methods of production and use of the patch are also disclosed.